Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Tax Provisions: 2019-2024

Historic Tax Provisions for Revolution Medicines (RVMD) over the last 5 years, with Dec 2024 value amounting to -$800,000.

  • Revolution Medicines' Tax Provisions fell 333.24% to -$800,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$4.4 million, marking a year-over-year decrease of 12.75%. This contributed to the annual value of -$800,000 for FY2024, which is 77.30% up from last year.
  • Per Revolution Medicines' latest filing, its Tax Provisions stood at -$800,000 for FY2024, which was up 77.30% from -$3.5 million recorded in FY2023.
  • Revolution Medicines' Tax Provisions' 5-year high stood at -$371,000 during FY2020, with a 5-year trough of -$3.5 million in FY2023.
  • Moreover, its 3-year median value for Tax Provisions was -$800,000 (2024), whereas its average is -$1.6 million.
  • Per our database at Business Quant, Revolution Medicines' Tax Provisions soared by 91.52% in 2020 and then crashed by 739.05% in 2023.
  • Yearly analysis of 4 years shows Revolution Medicines' Tax Provisions stood at -$371,000 in 2020, then reached -$420,000 in 2022, then slumped by 739.05% to -$3.5 million in 2023, then soared by 77.30% to -$800,000 in 2024.